# Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

> **NCT00004981** · PHASE3 · UNKNOWN · sponsor: **Glaxo Wellcome** · enrollment: 230 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Abacavir sulfate, Lamivudine and Zidovudine
- **DRUG:** Lamivudine/Zidovudine
- **DRUG:** Abacavir sulfate

## Key facts

- **NCT ID:** NCT00004981
- **Lead sponsor:** Glaxo Wellcome
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 230 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004981, "Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00004981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*